AQR Capital Management
CATX icon

AQR Capital Management’s Perspective Therapeutics CATX Stock Holding History

AQR Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Buy
+26,716
New +$113K ﹤0.01% 3673
2015
Q4 		– Sell
-7,216
Closed -$101K – 2244
2015
Q3 		$101K Sell
7,216
-10,027
-58% -$145K ﹤0.01% 2128
2015
Q2 		$255K Sell
17,243
-1,227
-7% -$19.9K ﹤0.01% 2037
2015
Q1 		$290K Sell
18,470
-770
-4% -$11.4K ﹤0.01% 1888
2014
Q4 		$281K Buy
19,240
+4,830
+34% +$76.5K ﹤0.01% 2230
2014
Q3 		$244K Buy
14,410
+4,850
+51% +$120K ﹤0.01% 2261
2014
Q2 		$298K Buy
+9,560
New +$240K ﹤0.01% 2217

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's CATX Position: Q1 2026 in Review

AQR Capital Management opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 26,716 shares worth $111K. The stake represents ﹤0.01% of the portfolio and ranks #3673 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in CATX as recently as Q3 2015.

AQR Capital Management first reported a position in CATX in Q2 2014 and has held it in 7 quarters since. The position peaked at $298K in Q2 2014. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • AQR Capital Management held 26,716 shares of Perspective Therapeutics worth $111K as of Q1 2026.
  • Perspective Therapeutics was a new AQR Capital Management position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3673 holding.
  • AQR Capital Management first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 7 quarters since.
  • AQR Capital Management's Perspective Therapeutics position peaked at $298K in Q2 2014.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.